Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function

PURPOSE: The Phase 3 LIBERTY ASTHMA QUEST study in patients aged ≥12 years with uncontrolled, moderate-to-severe asthma demonstrated the efficacy and safety of dupilumab 200 mg and 300 mg every 2 weeks (q2w) vs matched placebo in the overall population. This post hoc analysis assessed dupilumab effi...

詳細記述

保存先:
書誌詳細
出版年:J Asthma Allergy
主要な著者: Pavord, Ian D, Siddiqui, Salman, Papi, Alberto, Corren, Jonathan, Sher, Lawrence D, Bardin, Philip, Langton, David, Park, Hae-Sim, Rice, Megan S, Deniz, Yamo, Rowe, Paul, Staudinger, Heribert W, Patel, Naimish, Ruddy, Marcella, Graham, Neil M H, Teper, Ariel
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751293/
https://ncbi.nlm.nih.gov/pubmed/33364789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S275068
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料